Anti-p15 INK4b antibody
4
(1 Review)
|
(48 Publications)
Rabbit Polyclonal p15 INK4b antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 48 publications. Immunogen corresponding to Synthetic Peptide within Human CDKN2B.
View Alternative Names
MTS2, CDKN2B, Cyclin-dependent kinase 4 inhibitor B, Multiple tumor suppressor 2, p14-INK4b, p15-INK4b, MTS-2, p15INK4B
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p15 INK4b antibody (AB53034)
ab53034 (2µg/ml) staining p15 INK4b in human colon carcinoma.
Sections were stained using an automated system (DAKO Autostainer Plus ), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0 . Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-p15 INK4b antibody (AB53034)
Immunofluorescence analysis of HeLa cells, using Anti-p15 INK4b antibody (ab53034). The picture on the right is blocked with the synthesized peptide.
- WB
Unknown
Western blot - Anti-p15 INK4b antibody (AB53034)
All lanes:
Western blot - Anti-p15 INK4b antibody (ab53034) at 1/500 dilution
Lane 1:
HeLa cell extract
Lane 2:
HeLa cell extract with peptide
Predicted band size: 15 kDa
Observed band size: 15 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-p15 INK4b antibody (AB53034)
Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (Dako PT Link), at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffers EDTA pH 9.0. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 minutes and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- WB
CiteAb
Western blot - Anti-p15 INK4b antibody (AB53034)
p15 INK4b western blot using anti-p15 INK4b antibody ab53034. Publication image and figure legend from Tanaka, T., Terai, Y., et al., 2017, PLoS One, PubMed 28472136.
ab53034 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab53034 please see the product overview.
(A) A Western blot analysis shows the expression of Rb and phospho-Rb protein in HEC1A and HEC108 cells. Both cell lines demonstrated expression of cyclin D1. Strong expression of p15, p16, p18 and p19, which act as inhibitors of CDK 4/6, was not seen. (B) Effect of PD-0332991 on phosphorylation of Rb protein. HEC1A (top) and HEC108 (bottom) cells showed a time- and concentration-dependent inhibition of Rb phosphorylation following treatment with a PD-0332991 inhibitor. However, PD-0332991 inhibited total Rb expression to a greater extent than phospho-Rb.
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P15 INK4b plays a significant role in controlling cell proliferation by modulating the transition from the G1 to S phase in the cell cycle. It does not function as part of a complex but works independently to inhibit CDKs. The protein ensures that cells do not divide uncontrollably thereby acting as a tumor suppressor. Its activity is required for proper response to various growth-inhibitory signals and maintaining cellular homeostasis.
Pathways
The regulation and inhibition of the cell cycle by p15 INK4b take place within the broader framework of the retinoblastoma (RB) tumor suppressor pathway and the TGF-beta signaling pathway. This protein is closely related to other CDK inhibitors like p16 INK4a (CDKN2A) and p18 INK4c and it functions in concert with these inhibitors to maintain control over cell division. Through these pathways p15 INK4b ensures that cell growth is checked under normal physiological conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (48)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 26: PubMed40564900
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:5360-5380 PubMed39349844
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 57:e13719 PubMed39021340
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 80:156 PubMed37208565
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:960601 PubMed36466895
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 29:866-877 PubMed36269797
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular & molecular biology letters 27:86 PubMed36209059
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:993525 PubMed36176277
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 132: PubMed35852856
2022
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 5:310 PubMed35383267
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com